Navigation Links
The Feinstein to collaborate with Sweden's Karolinska Institute
Date:4/9/2008

MANHASSET, NY As part of its global mission of advancing science, The Feinstein Institute for Medical Research announced today that it has signed a collaborative agreement with the renowned Karolinska Institutet in Sweden. The agreement paves the way for Karolinska graduates to conduct post-doctoral research in New York and scientists from The Feinstein to study at the Karolinskas laboratories in Stockholm.

The Karolinska Institutet is always looking for outstanding training environments for their graduates, said Kevin J. Tracey, MD, director and chief executive of The Feinstein. And we want the students of our Elmezzi Graduate School of Molecular Medicine to have a challenging post-doctoral career as well. It couldnt be a better fit.

According to the agreement, both institutes have established joint programs to enhance the training and research of each institutes students and post-doctoral researchers. The collaboration will mean that as many as half a dozen scientists may be able to study abroad and that Feinstein scientists can host an equal number of Karolinskas post-doctoral students. They will still have to apply for a seat in the lab in New York or abroad, and a joint admissions committee from both institutes will review the applications and make the selections.

Our mission is translational research, and we offer a progressive basic and clinical training environment, added Dr. Tracey, an immunologist who collaborated with Karolinskas Jan Andersson, M.D., the head of infectious diseases, studying cytokines and inflammation. Dr. Andersson was also the first invited lecturer for The Feinstein Institutes Marsh lecture in 2005. His research includes the study of the potential role of regulatory T-cells in HIV/AIDS. He has discovered that HIV infection is associated with an increase of regulatory T-cells that negatively affect the capacity to mount a fully functional CD8 T-cell response against the infection. These regulatory T-cells could become a target for future treatments to reconstitute the immune system damaged by HIV infection.

The graduate students at the Karolinska and The Feinstein are medical doctors who have gone on to obtain a doctoral degree in research. The faculty leadership is always looking for the best and brightest post-doctoral students, said Dr. Tracey. These students are the heart of the lab.


'/>"/>

Contact: Jamie Talan
jtalan@nshs.edu
516-562-1232
North Shore-Long Island Jewish (LIJ) Health System
Source:Eurekalert

Related medicine news :

1. Sens. Kerry, Boxer and Feinstein call on FDA to Establish Maximum Level for Lead in Lipstick
2. The Wistar Institute collaborates with the Coriell Institute to distribute cell lines
3. INCF and Allen Institute for Brain Science collaborate on Brain Atlas service improvement
4. AMA Foundation and ReachMD Collaborate to Broadcast Excellence in Medicine Awards
5. The National ePrescribing Patient Safety Initiative Collaborates With Google
6. Quest Diagnostics to Collaborate with Google on New Health Offering
7. Researchers collaborate to find new vaccine technology decreases E. coli in beef cattle
8. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
9. Cleveland Clinic Collaborates with Google
10. BayCare Health System Collaborates With Accenx to Provide Reliable Exchange of Information
11. Geisinger and Celera to collaborate on liver disease test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... PurhealthRX , a leading Health and Nutrition Company, is announcing the ... spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the amount ... into liquid products, while reducing costs to end users. , The team of researchers ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... http://www.rebound-solution.com/ ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
Breaking Medicine Technology: